Feature Stories

Combining local innovation & frugal engineering.

Illumina, Trivitron collaborate for development, expansion of NGS-based tests in India

14 - March - 2022

Over the next four years, Illumina and Trivitron intend to develop and distribute a suite of standardised, commercial IVD assays to deliver an effective and non-invasive way of diagnosing cancers, determining infectious pathogens, and identifying prenatal diseases.

Visit Site